Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America

BACKGROUND: Despite the abundance of information concerning ocrelizumab in phase III clinical trials, there is scarce evidence regarding real-world patient profiles. OBJECTIVE: The aim of this study was to investigate patient profiles, effectiveness and persistence with treatment among patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: ROJAS, Juan Ignacio, PATRUCCO, Liliana, FRUNS, Manuel, HORNUNG, Giesela, FLORES, José, CARNERO CONTENTTI, Edgar, LOPEZ, Pablo Adrian, PETTINICCHI, Juan Pablo, CARIDE, Alejandro, GALLEGUILLOS, Lorna, BARAHONA, Jorge, DIAZ, Violeta, HERNÁNDEZ, Marianella, ALONSO, Ricardo, CRISTIANO, Edgardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academia Brasileira de Neurologia - ABNEURO 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231439/
https://www.ncbi.nlm.nih.gov/pubmed/34133511
http://dx.doi.org/10.1590/0004-282X-ANP-2020-0339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231439/
https://www.ncbi.nlm.nih.gov/pubmed/34133511
http://dx.doi.org/10.1590/0004-282X-ANP-2020-0339

Ejemplares similares